Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina Russo

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 8, 2012
Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesionsSebastiano Gangemi, Alessandro Allegra, Andrea Alonci, et al.
Clinical Biochemistry|September 28, 2011
Carbonyl group serum levels are associated with CD38 expression in patients with B chronic lymphocytic leukemiaCaterina Musolino, Alessandro Allegra, Andrea Alonci, et al.
Cancer Investigation|January 13, 2012
Relationship between advanced oxidation protein products, advanced glycation end products, and S-nitrosylated proteins with biological risk and MDR-1 polymorphisms in patients affected by B-chronic lymphocytic leukemiaSebastiano Gangemi, Alessandro Allegra, Mohamed Aguennouz, et al.
Cellular Immunology|November 6, 2012
Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemiaSebastiano Gangemi, Alessandro Allegra, Elisabetta Pace, et al.
Clinical Biochemistry|August 2, 2012
Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemiaCaterina Musolino, Alessandro Allegra, Antonella Saija, et al.
International Journal of Molecular Sciences|March 13, 2025
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the <i>BCR::ABL1</i> Transcript LevelFabio Stagno, Stefania Stella, Salvatore Leotta, et al.
In Vivo (Athens, Greece)|September 1, 2019
Successful Management of a Pregnant Patient With Chronic Myeloid Leukemia Receiving Standard Dose ImatinibStefania Stella, Elena Tirró, Michele Massimino, et al.
Haematologica|September 22, 2011
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano mutation)Patrizia Noris, Silverio Perrotta, Roberta Bottega, et al.
Cancers|April 3, 2021
Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded ImmunoliposomeMohammad Houshmand, Francesca Garello, Rachele Stefania, et al.
International Journal of Molecular Sciences|May 9, 2019
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with ImatinibStefania Stella, Valentina Zammit, Silvia Rita Vitale, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 8, 2012
Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesionsSebastiano Gangemi, Alessandro Allegra, Andrea Alonci, et al.
Clinical Biochemistry|September 28, 2011
Carbonyl group serum levels are associated with CD38 expression in patients with B chronic lymphocytic leukemiaCaterina Musolino, Alessandro Allegra, Andrea Alonci, et al.
Cancer Investigation|January 13, 2012
Relationship between advanced oxidation protein products, advanced glycation end products, and S-nitrosylated proteins with biological risk and MDR-1 polymorphisms in patients affected by B-chronic lymphocytic leukemiaSebastiano Gangemi, Alessandro Allegra, Mohamed Aguennouz, et al.
Cellular Immunology|November 6, 2012
Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemiaSebastiano Gangemi, Alessandro Allegra, Elisabetta Pace, et al.
Clinical Biochemistry|August 2, 2012
Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemiaCaterina Musolino, Alessandro Allegra, Antonella Saija, et al.
International Journal of Molecular Sciences|March 13, 2025
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the <i>BCR::ABL1</i> Transcript LevelFabio Stagno, Stefania Stella, Salvatore Leotta, et al.
In Vivo (Athens, Greece)|September 1, 2019
Successful Management of a Pregnant Patient With Chronic Myeloid Leukemia Receiving Standard Dose ImatinibStefania Stella, Elena Tirró, Michele Massimino, et al.
Haematologica|September 22, 2011
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano mutation)Patrizia Noris, Silverio Perrotta, Roberta Bottega, et al.
Cancers|April 3, 2021
Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded ImmunoliposomeMohammad Houshmand, Francesca Garello, Rachele Stefania, et al.
International Journal of Molecular Sciences|May 9, 2019
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with ImatinibStefania Stella, Valentina Zammit, Silvia Rita Vitale, et al.
Pageof 5